Utah Approves AI-Generated Acne Prescriptions from Nolla Health
In a groundbreaking move for digital healthcare, Utah has granted regulatory approval to Nolla Health, a startup that uses artificial intelligence to scan users' faces and directly issue prescription acne treatments. This makes Utah the first U.S. state to permit an AI system to autonomously prescribe medication, marking a significant shift in how medical care can be delivered.
How Nolla Health's AI Works
Nolla Health's system uses a smartphone camera to capture images of a user's face. The AI analyzes the images to assess acne severity and type, then generates a prescription for topical or oral medications if deemed appropriate. The entire process is automated, with no human doctor involved in the initial prescription. However, the company says patients can consult with a licensed physician if needed.
The approval from Utah's Division of Professional Licensing allows Nolla Health to operate within the state, though the company plans to expand to other states pending regulatory clearance.
Regulatory and Ethical Considerations
While the move is praised for increasing access to dermatological care—especially in underserved areas—it raises questions about safety, accountability, and the role of AI in medical decision-making. The U.S. Food and Drug Administration (FDA) has not yet issued specific guidelines for AI-powered prescription systems, leaving state-level regulators to fill the gap.
Critics argue that without human oversight, AI could misdiagnose conditions or overlook serious skin issues. Nolla Health counters that its AI has been trained on millions of dermatological images and has demonstrated high accuracy in clinical trials. The company also emphasizes that patients can request a human review at any time.
The Broader Trend of AI in Healthcare
Nolla Health's approval comes amid a surge in AI-driven healthcare solutions. In 2025, several telehealth platforms began integrating AI triage tools, and by 2026, more states are expected to consider similar regulations. The global AI healthcare market is projected to reach $187 billion by 2030, according to industry analysts.
As AI continues to permeate medicine, Utah's decision could serve as a blueprint for other states. It also highlights the need for updated regulatory frameworks that ensure safety while fostering innovation.
What's Next for Nolla Health
Nolla Health plans to launch its service in Utah in early 2026 and is in talks with several other states. The company is also exploring partnerships with insurance providers to cover AI-prescribed treatments. If successful, this model could revolutionize not just dermatology but other areas of medicine where routine prescriptions are common.
For now, Utah's approval is a bold experiment in trusting machines with medical authority—one that will be closely watched by regulators, doctors, and patients alike.
via The Verge